Exceptional response to cetuximab monotherapy in a patient with metastatic oropharyngeal squamous cell carcinoma: a molecular insight

BACKGROUND: Metastatic head and neck squamous cell carcinoma (HNSCC) carries a very poor prognosis. A better understanding of the molecular driver of the disease and the identification of biomarkers of response remain paramount for an effective personalized therapy. CASE REPORT: We report an origina...

Descripción completa

Detalles Bibliográficos
Autores principales: Peddi, Prakash, Paryani, Bhavna, Takalkar, Amol, Bundrick, Paige, Ponugupati, John, Nair, Binu, El-Osta, Hazem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755421/
https://www.ncbi.nlm.nih.gov/pubmed/26929641
http://dx.doi.org/10.2147/OTT.S99667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755421/
https://www.ncbi.nlm.nih.gov/pubmed/26929641
http://dx.doi.org/10.2147/OTT.S99667

Ejemplares similares